Kevin Atchison

2.7k total citations
19 papers, 854 citations indexed

About

Kevin Atchison is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Kevin Atchison has authored 19 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 5 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Kevin Atchison's work include Alzheimer's disease research and treatments (7 papers), Neuroscience and Neuropharmacology Research (3 papers) and Memory and Neural Mechanisms (3 papers). Kevin Atchison is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Neuroscience and Neuropharmacology Research (3 papers) and Memory and Neural Mechanisms (3 papers). Kevin Atchison collaborates with scholars based in United States, Canada and Germany. Kevin Atchison's co-authors include David Riddell, Hua Zhou, Suzan Aschmies, Menelas N. Pangalos, George E. Davis, Ashley L. Siegel, DDW Cornelison, Kevin E. Fisher, Margaret M. Zaleska and Peter H. Reinhart and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and Cancer Research.

In The Last Decade

Kevin Atchison

19 papers receiving 839 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Atchison United States 10 445 368 194 164 133 19 854
María Isabel González United Kingdom 9 454 1.0× 182 0.5× 219 1.1× 120 0.7× 43 0.3× 12 607
Rosanne Catalano United States 12 836 1.9× 537 1.5× 328 1.7× 174 1.1× 49 0.4× 13 1.2k
Alfredo Giménez-Cassina Spain 21 382 0.9× 979 2.7× 314 1.6× 91 0.6× 58 0.4× 29 1.5k
Mar Pacheco‐Herrero Dominican Republic 15 430 1.0× 322 0.9× 113 0.6× 122 0.7× 38 0.3× 23 967
Patricia Spilman United States 15 767 1.7× 695 1.9× 198 1.0× 282 1.7× 43 0.3× 26 1.5k
Zhi‐Wang Li China 16 189 0.4× 367 1.0× 224 1.2× 156 1.0× 42 0.3× 48 750
Jérôme Braudeau France 10 328 0.7× 331 0.9× 128 0.7× 72 0.4× 98 0.7× 20 726
Carlos Morgan Chile 13 351 0.8× 235 0.6× 94 0.5× 166 1.0× 27 0.2× 26 716
J. K. Blusztajn United States 13 598 1.3× 414 1.1× 227 1.2× 150 0.9× 23 0.2× 17 992

Countries citing papers authored by Kevin Atchison

Since Specialization
Citations

This map shows the geographic impact of Kevin Atchison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Atchison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Atchison more than expected).

Fields of papers citing papers by Kevin Atchison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Atchison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Atchison. The network helps show where Kevin Atchison may publish in the future.

Co-authorship network of co-authors of Kevin Atchison

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Atchison. A scholar is included among the top collaborators of Kevin Atchison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Atchison. Kevin Atchison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Malkova, Natalia V., Tatiana Tolstykh, Mikhail Levit, et al.. (2020). Abstract 4451: Combination of local mRNA immunotherapy with systemic immune checkpoint blockade demonstrates anti-tumor activity across a diverse range of preclinical syngeneic tumor models. Cancer Research. 80(16_Supplement). 4451–4451. 2 indexed citations
2.
Zuhl, Andrea M., Charles E. Nolan, Michael A. Brodney, et al.. (2016). Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors. Nature Communications. 7(1). 13042–13042. 59 indexed citations
3.
Gonzales, Cathleen, Margaret M. Zaleska, David Riddell, et al.. (2014). Alternative method of oral administration by peanut butter pellet formulation results in target engagement of BACE1 and attenuation of gavage-induced stress responses in mice. Pharmacology Biochemistry and Behavior. 126. 28–35. 40 indexed citations
4.
Hajós, Mihály, Elena Morozova, Chester J. Siok, et al.. (2013). Effects of the γ-secretase inhibitor semagacestat on hippocampal neuronal network oscillation. Frontiers in Pharmacology. 4. 72–72. 10 indexed citations
5.
Ambroise, Claude, Rafael G. da Silva, Kevin Atchison, et al.. (2013). P4–288: Effect of A673T mutation on APP processing by BACE1 and its significance for Alzheimer's disease therapeutic research. Alzheimer s & Dementia. 9(4S_Part_20). 1 indexed citations
6.
Feng, Jianlin, Tamás Kiss, Elie Needle, et al.. (2012). Age-dependent disruption in hippocampal theta oscillation in amyloid-β overproducing transgenic mice. Neurobiology of Aging. 33(7). 1481.e13–1481.e23. 69 indexed citations
7.
Oborski, Christine, Bruce A. Maguire, Kevin Atchison, et al.. (2012). Pharmacological Assessment of <i>γ</i>-Secretase Activity from Rodent and Human Brain. Neuroscience & Medicine. 3(2). 149–161. 3 indexed citations
8.
Lu, Yasong, Liming Zhang, Charles E. Nolan, et al.. (2011). Quantitative Pharmacokinetic/Pharmacodynamic Analyses Suggest That the 129/SVE Mouse Is a Suitable Preclinical Pharmacology Model for Identifying Small-Molecule γ-Secretase Inhibitors. Journal of Pharmacology and Experimental Therapeutics. 339(3). 922–934. 19 indexed citations
9.
Warwick, Helen K., Julius J. Jefferson, Kevin Atchison, et al.. (2009). P4‐050: Dysregulation of brain ApoE and cholesterol metabolism in APP transgenic mice. Alzheimer s & Dementia. 5(4S_Part_15). 1 indexed citations
10.
Siegel, Ashley L., Kevin Atchison, Kevin E. Fisher, George E. Davis, & DDW Cornelison. (2009). 3D Timelapse Analysis of Muscle Satellite Cell Motility. Stem Cells. 27(10). 2527–2538. 133 indexed citations
11.
Riddell, David, Hua Zhou, Kevin Atchison, et al.. (2008). Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels. Journal of Neuroscience. 28(45). 11445–11453. 277 indexed citations
12.
Kreft, Anthony F., Magid Abou‐Gharbia, Ann Aulabaugh, et al.. (2008). P2‐337: Characterization of the affinity of GSI‐953 for binding to gamma‐secretase and comparison to benchmark gamma‐secretase inhibitors. Alzheimer s & Dementia. 4(4S_Part_14). 2 indexed citations
13.
Comery, Thomas A., Robert Martone, Suzan Aschmies, et al.. (2005). Acute γ-Secretase Inhibition Improves Contextual Fear Conditioning in the Tg2576 Mouse Model of Alzheimer's Disease. Journal of Neuroscience. 25(39). 8898–8902. 176 indexed citations
14.
Hyodo, Akio, Norio Unemi, Samarendra N. Maiti, et al.. (1999). In Vitro and In Vivo Activities of Syn2190, a Novel β-Lactamase Inhibitor. Antimicrobial Agents and Chemotherapy. 43(8). 1895–1900. 25 indexed citations
15.
Phillips, Oludotun A., et al.. (1998). Studies on monobactams I. Synthesis and β-lactamase inhibitory activity of 4-substituted 3-[(N-methyl-1,2,3-triazol-4-yl)-methylene]-2-azetidinone-1-sulfonates. Chemistry of Heterocyclic Compounds. 34(11). 1308–1318. 3 indexed citations
16.
Setti, Eduardo L., Oludotun A. Phillips, Kevin Atchison, et al.. (1997). Studies on penam sulfones. II. Synthesis and beta-lactamase inhibitory activity of 2 beta-carboxamide penicillanic acid sulfones. PubMed. 50(3). 276–8. 1 indexed citations
17.
Xie, Guojian, Rajan Gupta, Kevin Atchison, & J. William Lown. (1996). Bisindolylmaleimides Linked to DNA Minor Groove Binding Lexitropsins:  Synthesis, Inhibitory Activity against Topoisomerase I, and Biological Evaluation. Journal of Medicinal Chemistry. 39(5). 1049–1055. 19 indexed citations
18.
Kamal, Ahmed, Kevin Atchison, Mohsen Daneshtalab, & Ronald G. Micetich. (1995). Synthesis of podophyllotoxin congeners as potential DNA topoisomerase II inhibitors.. PubMed. 10(7). 545–54. 9 indexed citations
19.
Kamal, Ahmed, Mohsen Daneshtalab, Kevin Atchison, & Ronald G. Micetich. (1994). Synthesis of ring-a-opened isopicropodophyllins as potential DNA topoisomerase II inhibitors. Bioorganic & Medicinal Chemistry Letters. 4(12). 1513–1518. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Isabel González Breakdown of academic impact, for papers by Rosanne Catalano Breakdown of academic impact, for papers by Alfredo Giménez-Cassina Breakdown of academic impact, for papers by Mar Pacheco‐Herrero Breakdown of academic impact, for papers by Patricia Spilman Breakdown of academic impact, for papers by Zhi‐Wang Li Breakdown of academic impact, for papers by Jérôme Braudeau Breakdown of academic impact, for papers by Carlos Morgan Breakdown of academic impact, for papers by J. K. Blusztajn
Rankless by CCL
2026